Editas (EDIT) Reports Upbeat New Data From Reni-Cel Studies
Yahoo Finance · 1 week ago
Open | 478.30 |
High | 483.92 |
Low | 475.78 |
Mkt Cap | 124.2B |
P/E (TTM) | 31.27 |
Div & Yield | N/A & N/A |
Prev. Close | 474.95 |
52 Wk. Low | 335.82 |
52 Wk. High | 486.43 |
Related stocks
American pharmaceutical company
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 2.69B | 13.30% ▲ |
Net Income | 1.1B | 57.10% ▲ |
Diluted EPS | 4.76 | 56.50% ▲ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $4.17 | - |
Q1 2024 | $4.06 | $4.76 |
Q4 2023 | $3.83 | $3.92 |
S&P 500^GSPC | 5,457.99+10.12 (+0.19%) |
Dow 30^DJI | 39,326.73-84.48 (-0.21%) |
Nasdaq^IXIC | 17,588.66+91.84 (+0.52%) |
27.86-16.21% | |
121.72+3.06% | |
MicroAlgo Inc.MLGO | 13.93-7.15% |